Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 11,521 | 11,038 | 11,758 | 8,313 | 11,963 |
| Cost of Goods | N/A | 400 | 380 | N/A | N/A |
| Gross Profit | 11,521 | 10,630 | 11,640 | 8,313 | 11,963 |
| Operating Expenses | 0 | 14,540 | 15,570 | 0 | 0 |
| Operating Income | 11,521 | -3,502 | -3,812 | 8,313 | 11,963 |
| Interest Expense | 0 | 60 | 0 | 0 | 0 |
| Other Income | 0 | 22 | 312 | 0 | 0 |
| Pre-tax Income | 11,521 | -3,540 | -3,500 | 8,313 | 11,963 |
| Income Tax | N/A | -450 | -510 | N/A | N/A |
| Net Income Continuous | -4,289 | -3,084 | -2,923 | 3,294 | -3,486 |
| Net Income | $-4,289 | $-3,084 | $-2,923 | $3,294 | $-3,486 |
| EPS Basic Total Ops | -0.29 | -0.24 | -0.26 | 0.29 | -0.32 |
| EPS Basic Continuous Ops | -0.29 | -0.24 | -0.26 | 0.29 | -0.32 |
| EPS Diluted Total Ops | -0.29 | -0.24 | -0.26 | 0.29 | -0.32 |
| EPS Diluted Continuous Ops | -0.29 | -0.24 | -0.26 | 0.29 | -0.32 |
| EBITDA(a) | $12,071 | $-3,142 | $-3,122 | $8,313 | $11,963 |